Curative effect of Zhiling capsule combined Valsartan on chronic nephropathy and its influence on renal function
-
摘要: 目的 探讨至灵胶囊联合缬沙坦治疗慢性肾病的疗效及对患者肾功能的影响。 方法 将76例慢性肾病患者按照随机数字表法分为观察组和对照组,每组38例。对照组采用缬沙坦治疗,观察组在对照组基础上给予至灵胶囊治疗,对比2组治疗效果。于治疗前及治疗后,检测2组患者的T淋巴细胞(CD3、CD4、CD4/CD8)、可溶性细胞黏附因子-1(sICAM-1)及肾功能指标[血肌酐(Scr)、血尿素氮(BUN)、尿白蛋白排泄率(UAER)、肾小球滤过率(GFR)]变化情况。 结果 观察组治疗效果显著优于对照组,差异有统计学意义(z=2.262,P<0.05)。观察组治疗后CD3显著升高,CD4、CD4/CD8、sICAM-1显著降低,差异有统计学意义(P<0.05);对照组治疗后sICAM-1显著下降(P<0.05)。治疗后,观察组CD3显著高于对照组,CD4、CD4/CD8、sICAM-1显著低于对照组,差异有统计学意义(t=6.642、6.734、5.462、2.319,P<0.05)。2组治疗后Scr、BUN、UAER显著降低,GFR显著升高,差异有统计学意义(P<0.05);治疗后,观察组Scr、BUN、UAER显著低于对照组,GFR显著高于对照组,差异有统计学意义(t=4.390、2.386、3.824、2.719,P<0.05)。 结论 至灵胶囊联合缬沙坦能显著改善慢性肾病患者的免疫功能,提高肾功能。Abstract: Objective To evaluate the clinical efficacy of Zhiling Capsule combined with Valsartan in the treatment of chronic nephropathy and its influence on renal function. Methods Total 76 cases of chronic kidney disease were divided into observation group and control group by random number table method with 38 cases in each group.The control group received Valsartan,while the observation group received additional Zhiling Capsule.The curative effect was compared between the two groups.Before and after the treatment,T lymphocytes(CD3,CD4,CD4/CD8),soluble cell adhesion factor-1(sICAM-1),renal function index(Scr,BUN,UAER,and GFR) of both groups were tested. Results The therapeutic efficacy in the observation group was significantly better than that in the control group,the difference was statistically significant(z=2.262,P<0.05).After the treatment,the level of CD3 in the observation group was significantly increased,inversely,the levels of CD4,CD4/CD8 and sICAM-1 were significantly decreased,the difference was statistically significant(P<0.05);but the level of sICAM-1 decreased significantly(P<0.05).After the treatment,the level of CD3 in the observation group was significantly higher than that of the control group,inversely,the levels of CD4,CD4/CD8 and sICAM-1 was significantly lower than those in the control group,the difference was statistically significant (t=6.642,6.734,5.462,2.319,P<0.05).After the treatment,the levels of Scr,BUN and UAER were all significantly decreased in both groups,and the level of GFR was significantly increased(P<0.05);The levels of Scr,BUN and UAER in the observation group were significantly lower than those in the control group,and the level of GFR was significantly higher than that of the control group(t=4.390,2.386,3.824,2.719,P<0.05). Conclusion Zhiling Capsule combined with Valsartan can significantly improve the immune function and renal function in patients with chronic kidney disease.
-
Key words:
- Zhiling capsule /
- Chronic kidney disease /
- Renal function /
- Valsartan
点击查看大图
计量
- 文章访问数: 65
- HTML全文浏览量: 16
- PDF下载量: 1
- 被引次数: 0